Godavari Biorefineries schedules AGM on Sep 28; reappoints Somaiya
- Godavari Biorefineries posts FY26 PAT of ₹123.62 lakh vs loss of ₹2,175.95 lakh in FY25
- Revenue rises to ₹1,96,492.02 lakh driven by higher operational income
- Finance costs drop significantly to ₹4,844.57 lakh from ₹7,160.79 lakh
- AGM to reappoint Samir S. Somaiya as MD and Dinesh Sharma as WTD
- Cost auditor remuneration ratified at ₹6.4 lakh per annum

*this image is generated using AI for illustrative purposes only.
Godavari Biorefineries has scheduled its 71st Annual General Meeting for September 28, 2026. The meeting will be conducted via video conferencing and other audio-visual means.
The agenda includes the adoption of audited financial statements for the fiscal year ended March 31, 2026. Shareholders will also vote on several special resolutions regarding board appointments and remuneration approvals.
Financial Performance
The company reported a significant turnaround in profitability for FY26 compared to the previous year. Revenue from operations rose to ₹1,96,492.02 lakh from ₹185,316.64 lakh in FY25.
| Metric | FY26 | FY25 |
|---|---|---|
| Revenue from Operations | ₹1,96,492.02 lakh | ₹185,316.64 lakh |
| PBDIT | ₹13,453.40 lakh | ₹11,606.18 lakh |
| Finance Costs | ₹4,844.57 lakh | ₹7,160.79 lakh |
| PAT (Before OCI) | ₹123.62 lakh | (₹2,175.95) lakh |
Profit before depreciation, interest, exceptional items, and tax increased to ₹13,453.40 lakh from ₹11,606.18 lakh. Finance costs declined sharply to ₹4,844.57 lakh from ₹7,160.79 lakh, aiding the bottom line. The company returned to profit after tax, reporting ₹123.62 lakh against a loss of ₹2,175.95 lakh in the prior year.
What the Numbers Show
The shift from a substantial loss to a modest profit was driven primarily by a reduction in finance costs rather than an expansion in operating margins. While PBDIT grew by approximately 15.9%, finance costs fell by nearly 32.4%. This divergence suggests that interest cost management played a larger role in the turnaround than operational leverage during the period.
Board Appointments
The meeting will seek approval for the reappointment of Samir S. Somaiya as Managing Director for three years, effective April 1, 2027. His remuneration includes a basic salary of ₹17,95,360 per month and a commission of 2% of net profit.
Suhas Godage is proposed for reappointment as Whole-Time Director (Executive Director, Works-Sakarwadi) for three years starting April 1, 2027. His package includes a basic salary of ₹254,190 per month and a performance incentive capped at ₹20 lakh annually.
Dinesh Sharma will be appointed as a director and subsequently as Whole-Time Director (Executive Director, Works-Sameerwadi) effective from the date of the AGM. He currently serves as Chief Technical Officer at the Sameerwadi unit. His remuneration includes a basic salary of ₹255,030 per month.
Dr Raman Ramchandran and Suhas Godage are retiring by rotation and offer themselves for reappointment as directors.
Other Business
The company seeks ratification for the remuneration of cost auditor M/s R. Nanabhoy & Co., amounting to ₹6,40,000 per annum plus taxes for the financial year ending March 31, 2027.
Shareholders will also vote on contributing up to ₹1,40,00,000 to charitable and other funds in any financial year. Additionally, approval is sought for accepting fixed deposits from the public and members under three schemes offering interest rates between 8.50% and 9.50% per annum depending on tenure.
Historical Stock Returns for Godavari Biorefineries
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.45% | +1.07% | -7.27% | -13.28% | -15.47% | 0.0% |
Can Godavari Biorefineries sustain its profitability in FY27 if operating margins do not improve, given that the recent turnaround was driven primarily by reduced finance costs rather than operational efficiency?
How will the proposed 2% commission on net profit for the Managing Director impact shareholder returns if the company's modest PAT levels persist or fluctuate?
What strategic advantages does the appointment of Dinesh Sharma as Whole-Time Director at the Sameerwadi unit bring, and how might this leadership change affect production efficiency at that specific facility?


































